Recent Blog Posts

View Post: ANTI-CANCER
19 hours ago
Slide 64: I. Each drug should be active when used alone against the particular cancer II. The drug should have different mechanism of action III. Cross resistant between drugs should be minimal. IV. The drugs should have different toxic effects. ... LEUKEMIA > ALL: induction: vincristine & prednisone >remission maintenance: mercaptopurine, methotrexate & cyclophosphamide in various combination ADULT LEUKEMIA > AML: cytarabine, mitoxantrone or daunorubicin or idarubicin ...
View Blog: Recent plicks from myplick.com - http://www.myplick.com/

---

View Post: Daunorubicin Versus Mitoxantrone Versus Idarubicin As Induction ...
6 Nov 2009 by Mandelli, Vignetti, Suciu, Stasi, Petti,...  
... the use of mitoxantrone or idarubicin instead of daunorubicin enhances the long-term efficacy of chemotherapy. Supported in part by Grants No. 2U10-CA11488-23 through 2U10-CA11488-36 from the National Cancer Institute, Bethesda, MD; ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/

---

View Post: Leukemia Clinical Trial: AEG35156 in Combination With High-dose ...
19 Nov 2009
To determine if AEG35156 can enhance the combined complete remission (CR) and CR with incomplete platelet recovery (CRp) rate of high-dose cytarabine and idarubicin in AML following failure of a single standard dose cytarabine based ... Current evidence of an active second malignancy except for non-melanoma skin cancer. Uncontrolled medical problems, unrelated to the malignancy, or of sufficient severity that in the opinion of the investigator, impair a patient's ability ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: IDARUBICIN MAYBE BETTER FOR AML
23 Oct 2009 by Dr. NICK  
Cardarelli" Hospital, Napoli, Italy; European Organisation for Research and Treatment of Cancer Data Center, Brussels, Belgium; Department of Hematology, Radboud University Medical Center, Nijmegen; Department of Hematology, ...
View Blog: CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/

---

View Post: high efficacy and low toxicity of apl induction with concurrent ...
6 Sep 2009 by Gulfoncology  
king faisal cancer centre, king faisal specialist hospital and research centre, po box 3354, riyadh, 11211, saudi arabia, maljurf@kfshrc.edu.sa. acute promyelocytic leukemia (apl) is one of the most curable myeloid malignancies because ...
View Blog: Araboncology - http://www.gulfoncology.org/blog/blog.html

---

View Post: Idamycin PFS (Idarubicin Hydrochloride Injection) Drug Information ...
9 Oct 2008
Your dose may need to be adjusted. USES: Idarubicin is used to treat a certain type of cancer (leukemia). It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells. ...
View Blog: RxList - News and Features - http://www.rxlist.com/script/main/hp.asp

---

View Post: Minstemann: AML, akutt myelogen leukemi
17 Jun 2007 by Heidi  
Chemotherapy -- drugs that destroy cancer cells or stop them from growing (described below). A bone marrow or cord blood transplant (described below). All-trans retinoic acid (ATRA) if he or she has the subtype of AML known as ... Cytarabine (ara-C); An anthracycline drug such as daunorubicin (Daunomycin) or idarubicin (Idamycin). Some patients may also be given additional drugs or different drugs. Patients who have the AML subtype promyelocytic leukemia also are given ...
View Blog: Minstemann - http://minstemann06.blogspot.com/

---

View Post: phase i and pharmacokinetic study of bortezomib in combination ...
3 Mar 2008 by Attar, E. C., DeAngelo, D. J., Supko, J....  
experimental design: bortezomib was given on days 1, 4, 8, and 11 at doses of 0.7, 1.0, 1.3, or 1.5 mg/m2 with idarubicin 12 mg/m2 on days 1 to 3 and cytarabine 100 mg/m2/day on days 1 to 7. results: a total of 31 patients were enrolled ...
View Blog: Clinical Cancer Research current issue - http://clincancerres.aacrjournals.org/

---

View Post: Britain's NHS? It's about as good as the health system in Slovenia ...
29 Sep 2009 by JR  
Anna McKenna, 56, was given four times the recommended daily amount of Idarubicin to treat her bone marrow cancer. Mother-of-five Mrs McKenna should have taken 60mg of the drug over four days, but was told to take 60mg per day. ...
View Blog: SOCIALIZED MEDICINE - http://socglory.blogspot.com/

---

View Post: GE E-Care Services Blog » Blog Archive » Introducing - Omega-6 ...
16 Nov 2009 by admin  
Chemotherapy for cancer — GLA may increase the effects of anti-cancer treatments, such as doxorubicin, cisplatin, carboplatin, idarubicin, mitoxantrone, tamoxifen, vincristine, and vinblastine. Cyclosporine — Taking omega-6 fatty acids ...
View Blog: GE E-Care Services Blog - http://www.gembpatients.com/blog/

---